Analyst Conference Summaries

Biotechnology Investor Aids

Dicerna Pharmaceuticals
DRNA

conference date: August 8, 2019 @ 1:30 PM Pacific Time

Dicerna: An RNA Therapy-Based 21st Century Likely Winner [July 12, 2019 at Seeking Alpha]

2019
  Dicerna (DRNA)
Q2 2019
   
  Aug. 8, 2019    

Dicerna Pharmaceuticals (DRNA) is a clinical-stage biotechnology company specializing in RNA therapies for genetic diseases.

Dicerna Pharmaceuticals web site


 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALNY
 ALXN
 AMAT
 AMGN
 BIIB
 CLDX
 CELG
 EPZM
 GILD
 GLYC
 INO
 ISRG
 MCHP
 MYL.
 PLX
 REGN
 SGEN
 TTPH
 VBLT
 VSTM
 XLNX
 XLRN
       

Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2019 William P. Meyers